Submitted:
18 September 2023
Posted:
19 September 2023
You are already at the latest version
Abstract

Keywords:
1. Introduction
2. Results
Culture parameters
HPLC-DAD-CAD
Molecular network and annotation
Biological activity
2.1. Micromonospora sp. SH-82
2.1.1. Influence of culture support and time
2.1.1.1. HPLC-CAD-DAD Analysis
2.1.1.2. Molecular network and annotations
2.1.1.3. Biological activity
2.1.2. Influence of culture medium and support
2.1.2.1. HPLC-CAD-DAD Analysis
2.1.2.2. Molecular network and annotations
2.1.2.3. Biological activity
2.1.3. Overview annotations
2.2. Micromonospora sp. SH-57
2.2.1. Influence of culture support and time
2.2.1.1. HPLC-CAD-DAD Analysis
2.2.1.3. Biological activity
2.2.2. Influence of culture medium and support
2.2.1.1. HPLC-CAD-DAD Analysis
2.2.1.2. Molecular network and annotations
2.2.3. Overview annotations
2.3. Salinispora arenicola SH-78
2.3.1. Influence of culture support
2.3.1.1. HPLC-CAD-DAD Analysis
2.3.1.2. Molecular network and annotations
2.3.2. Influence of culture time
2.3.2.1. HPLC-CAD-DAD Analysis
2.3.2.2. Molecular network and annotations
2.3.3. Influence of culture solvent
2.3.3.1. Molecular network and annotations
2.3.3.2. Biological activity
2.3.4. Overview annotations
3. Discussion
4. Materials and Methods
4.1. Biological material (Sponge/Microbial strains)
4.2. Cultivation of strains using the “One Strain Many Compounds” (OSMAC) method
4.3. Microbials extracts preparation
4.4. Chemical Analysis
4.4.1. HPLC-DAD-CAD analysis
4.4.1. UHPLC-QTOF-MS/MS Analysis
4.5. Raw data processing, ion identity molecular network and annotations
4.6. Biological Activity Tests
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Non Communicable Diseases. Available online: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases (accessed on 19 April 2023).
- The Top 10 Causes of Death. Available online: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death (accessed on 19 April 2023).
- World Health Organization World Malaria Report 2021; World Health Organization: Geneva, 2021; ISBN 978-92-4-004049-6.
- Cancer (IARC), T.I.A. for R. on Global Cancer Observatory. Available online: https://gco.iarc.fr/ (accessed on 12 May 2023).
- Huemer, M.; Mairpady Shambat, S.; Brugger, S.D.; Zinkernagel, A.S. Antibiotic Resistance and Persistence-Implications for Human Health and Treatment Perspectives. EMBO Rep 2020, 21, e51034. [Google Scholar] [CrossRef]
- Newman, D.J.; Cragg, G.M. Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. J Nat Prod 2020, 83, 770–803. [Google Scholar] [CrossRef] [PubMed]
- Lu, W.-Y.; Li, H.-J.; Li, Q.-Y.; Wu, Y.-C. Application of Marine Natural Products in Drug Research. Bioorg Med Chem 2021, 35, 116058. [Google Scholar] [CrossRef] [PubMed]
- Jose, P.A.; Maharshi, A.; Jha, B. Actinobacteria in Natural Products Research: Progress and Prospects. Microbiological Research 2021, 246, 126708. [Google Scholar] [CrossRef]
- Srinivasan, R.; Kannappan, A.; Shi, C.; Lin, X. Marine Bacterial Secondary Metabolites: A Treasure House for Structurally Unique and Effective Antimicrobial Compounds. Mar Drugs 2021, 19, 530. [Google Scholar] [CrossRef] [PubMed]
- Subramani, R.; Sipkema, D. Marine Rare Actinomycetes: A Promising Source of Structurally Diverse and Unique Novel Natural Products. Mar Drugs 2019, 17. [Google Scholar] [CrossRef] [PubMed]
- Bauermeister, A.; Velasco-Alzate, K.; Dias, T.; Macedo, H.; Ferreira, E.G.; Jimenez, P.C.; Lotufo, T.M.C.; Lopes, N.P.; Gaudêncio, S.P.; Costa-Lotufo, L.V. Metabolomic Fingerprinting of Salinispora From Atlantic Oceanic Islands. Front Microbiol 2018, 9, 3021. [Google Scholar] [CrossRef]
- Hassan, S.S.U.; Shaikh, A.L. Marine Actinobacteria as a Drug Treasure House. Biomed Pharmacother 2017, 87, 46–57. [Google Scholar] [CrossRef]
- Barka, E.A.; Vatsa, P.; Sanchez, L.; Gaveau-Vaillant, N.; Jacquard, C.; Klenk, H.-P.; Clément, C.; Ouhdouch, Y.; van Wezel, G.P. Taxonomy, Physiology, and Natural Products of Actinobacteria. Microbiol Mol Biol Rev 2015, 80, 1–43. [Google Scholar] [CrossRef]
- Bahrami, Y.; Bouk, S.; Kakaei, E.; Taheri, M. Natural Products from Actinobacteria as a Potential Source of New Therapies Against Colorectal Cancer: A Review. Front Pharmacol 2022, 13, 929161. [Google Scholar] [CrossRef]
- Jensen, P.R.; Moore, B.S.; Fenical, W. The Marine Actinomycete Genus Salinispora: A Model Organism for Secondary Metabolite Discovery. Nat Prod Rep 2015, 32, 738–751. [Google Scholar] [CrossRef] [PubMed]
- Xiao, F.; Li, H.; Xu, M.; Li, T.; Wang, J.; Sun, C.; Hong, K.; Li, W. Staurosporine Derivatives Generated by Pathway Engineering in a Heterologous Host and Their Cytotoxic Selectivity. J. Nat. Prod. 2018, 81, 1745–1751. [Google Scholar] [CrossRef] [PubMed]
- Park, B.; Abdel-Azeem, A.; Al-Sanea, M.; Yoo, K.; Tae, J.; Lee, S. Staurosporine Analogues from Microbial and Synthetic Sources and Their Biological Activities. CMC 2013, 20, 3872–3902. [Google Scholar] [CrossRef] [PubMed]
- Reen, F.J.; Romano, S.; Dobson, A.D.W.; O’Gara, F. The Sound of Silence: Activating Silent Biosynthetic Gene Clusters in Marine Microorganisms. Mar Drugs 2015, 13, 4754–4783. [Google Scholar] [CrossRef]
- Brakhage, A.A.; Schuemann, J.; Bergmann, S.; Scherlach, K.; Schroeckh, V.; Hertweck, C. Activation of Fungal Silent Gene Clusters: A New Avenue to Drug Discovery. Prog Drug Res 2008, 66, 1, 3–12. [Google Scholar] [CrossRef] [PubMed]
- Netzker, T.; Fischer, J.; Weber, J.; Mattern, D.J.; König, C.C.; Valiante, V.; Schroeckh, V.; Brakhage, A.A. Microbial Communication Leading to the Activation of Silent Fungal Secondary Metabolite Gene Clusters. Front Microbiol 2015, 6, 299. [Google Scholar] [CrossRef]
- Okada, B.K.; Seyedsayamdost, M.R. Antibiotic Dialogues: Induction of Silent Biosynthetic Gene Clusters by Exogenous Small Molecules. FEMS Microbiology Reviews 2017, 41, 19–33. [Google Scholar] [CrossRef]
- Pinedo-Rivilla, C.; Aleu, J.; Durán-Patrón, R. Cryptic Metabolites from Marine-Derived Microorganisms Using OSMAC and Epigenetic Approaches. Mar Drugs 2022, 20, 84. [Google Scholar] [CrossRef]
- Romano, S.; Jackson, S.A.; Patry, S.; Dobson, A.D.W. Extending the “One Strain Many Compounds” (OSMAC) Principle to Marine Microorganisms. Mar Drugs 2018, 16, 244. [Google Scholar] [CrossRef]
- Palma Esposito, F.; Giugliano, R.; Della Sala, G.; Vitale, G.A.; Buonocore, C.; Ausuri, J.; Galasso, C.; Coppola, D.; Franci, G.; Galdiero, M.; et al. Combining OSMAC Approach and Untargeted Metabolomics for the Identification of New Glycolipids with Potent Antiviral Activity Produced by a Marine Rhodococcus. Int J Mol Sci 2021, 22, 9055. [Google Scholar] [CrossRef]
- Zhang, X.; Chen, L.; Chai, W.; Lian, X.-Y.; Zhang, Z. A Unique Indolizinium Alkaloid Streptopertusacin A and Bioactive Bafilomycins from Marine-Derived Streptomyces sp. HZP-2216E. Phytochemistry 2017, 144, 119–126. [Google Scholar] [CrossRef] [PubMed]
- Fan, B.; Parrot, D.; Blümel, M.; Labes, A.; Tasdemir, D. Influence of OSMAC-Based Cultivation in Metabolome and Anticancer Activity of Fungi Associated with the Brown Alga Fucus Vesiculosus. Mar Drugs 2019, 17, 67. [Google Scholar] [CrossRef] [PubMed]
- Said Hassane, C.; Fouillaud, M.; Le Goff, G.; Sklirou, A.D.; Boyer, J.B.; Trougakos, I.P.; Jerabek, M.; Bignon, J.; de Voogd, N.J.; Ouazzani, J.; et al. Microorganisms Associated with the Marine Sponge Scopalina Hapalia: A Reservoir of Bioactive Molecules to Slow Down the Aging Process. Microorganisms 2020, 8, E1262. [Google Scholar] [CrossRef]
- Schmid, R.; Petras, D.; Nothias, L.-F.; Wang, M.; Aron, A.T.; Jagels, A.; Tsugawa, H.; Rainer, J.; Garcia-Aloy, M.; Dührkop, K.; et al. Ion Identity Molecular Networking for Mass Spectrometry-Based Metabolomics in the GNPS Environment. Nat Commun 2021, 12, 3832. [Google Scholar] [CrossRef]
- Shannon, P.; Markiel, A.; Ozier, O.; Baliga, N.S.; Wang, J.T.; Ramage, D.; Amin, N.; Schwikowski, B.; Ideker, T. Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks. Genome Res 2003, 13, 2498–2504. [Google Scholar] [CrossRef] [PubMed]
- Wang, M.; Carver, J.J.; Phelan, V.V.; Sanchez, L.M.; Garg, N.; Peng, Y.; Nguyen, D.D.; Watrous, J.; Kapono, C.A.; Luzzatto-Knaan, T.; et al. Sharing and Community Curation of Mass Spectrometry Data with Global Natural Products Social Molecular Networking. Nat Biotechnol 2016, 34, 828–837. [Google Scholar] [CrossRef] [PubMed]
- Dührkop, K.; Fleischauer, M.; Ludwig, M.; Aksenov, A.A.; Melnik, A.V.; Meusel, M.; Dorrestein, P.C.; Rousu, J.; Böcker, S. SIRIUS 4: A Rapid Tool for Turning Tandem Mass Spectra into Metabolite Structure Information. Nat Methods 2019, 16, 299–302. [Google Scholar] [CrossRef]
- Dührkop, K.; Shen, H.; Meusel, M.; Rousu, J.; Böcker, S. Searching Molecular Structure Databases with Tandem Mass Spectra Using CSI:FingerID. Proc Natl Acad Sci U S A 2015, 112, 12580–12585. [Google Scholar] [CrossRef]
- Allard, P.-M.; Péresse, T.; Bisson, J.; Gindro, K.; Marcourt, L.; Pham, V.C.; Roussi, F.; Litaudon, M.; Wolfender, J.-L. Integration of Molecular Networking and In-Silico MS/MS Fragmentation for Natural Products Dereplication. Anal. Chem. 2016, 88, 3317–3323. [Google Scholar] [CrossRef]
- Rutz, A.; Dounoue-Kubo, M.; Ollivier, S.; Bisson, J.; Bagheri, M.; Saesong, T.; Ebrahimi, S.N.; Ingkaninan, K.; Wolfender, J.-L.; Allard, P.-M. Taxonomically Informed Scoring Enhances Confidence in Natural Products Annotation. Frontiers in Plant Science 2019, 10. [Google Scholar] [CrossRef]
- Pluskal, T.; Castillo, S.; Villar-Briones, A.; Orešič, M. MZmine 2: Modular Framework for Processing, Visualizing, and Analyzing Mass Spectrometry-Based Molecular Profile Data. BMC Bioinformatics 2010, 11, 395. [Google Scholar] [CrossRef] [PubMed]
- Rajput, A.; Dominguez San Martin, I.; Rose, R.; Beko, A.; LeVea, C.; Sharratt, E.; Mazurchuk, R.; Hoffman, R.M.; Brattain, M.G.; Wang, J. Characterization of HCT116 Human Colon Cancer Cells in an Orthotopic Model. Journal of Surgical Research 2008, 147, 276–281. [Google Scholar] [CrossRef] [PubMed]
- Welsh, J. Chapter 40 - Animal Models for Studying Prevention and Treatment of Breast Cancer. In Animal Models for the Study of Human Disease; Conn, P.M., Ed.; Academic Press: Boston, 2013; pp. 997–1018. ISBN 978-0-12-415894-8. [Google Scholar]
- Gaudêncio, S.P.; Bayram, E.; Lukić Bilela, L.; Cueto, M.; Díaz-Marrero, A.R.; Haznedaroglu, B.Z.; Jimenez, C.; Mandalakis, M.; Pereira, F.; Reyes, F.; et al. Advanced Methods for Natural Products Discovery: Bioactivity Screening, Dereplication, Metabolomics Profiling, Genomic Sequencing, Databases and Informatic Tools, and Structure Elucidation. Mar Drugs 2023, 21, 308. [Google Scholar] [CrossRef] [PubMed]
- Le Goff, G.; Adelin, E.; Cortial, S.; Servy, C.; Ouazzani, J. Application of Solid-Phase Extraction to Agar-Supported Fermentation. Bioprocess Biosyst Eng 2013, 36, 1285–1290. [Google Scholar] [CrossRef]
- Conn, P.M. Animal Models for the Study of Human Disease; Elsevier Science, 2013; ISBN 978-0-12-415894-8.
- Marquez, J.; Murawski, A.; Wagman, G.H.; Jaret, R.S.; Reimann, H. ISOLATION, PURIFICATION AND PRELIMINARY CHARACTERIZATION OF MEGALOMICIN. J. Antibiot. 1969, 22, 259–264. [Google Scholar] [CrossRef]
- Useglio, M.; Peirú, S.; Rodríguez, E.; Labadie, G.R.; Carney, J.R.; Gramajo, H. TDP-l-Megosamine Biosynthesis Pathway Elucidation and Megalomicin A Production in Escherichia Coli. Applied and Environmental Microbiology 2010, 76, 3869. [Google Scholar] [CrossRef]
- MetaCyc: Metabolic Pathways From All Domains of Life. Available online: https://metacyc.org/ (accessed on 27 July 2023).
- Goodman, C.; Useglio, M.; Peirú, S.; Labadie, G.; Mcfadden, G.; Rodriguez, E.; Gramajo, H. Chemobiosynthesis of New Antimalarial Macrolides. Antimicrobial agents and chemotherapy 2012, 57. [Google Scholar] [CrossRef]
- Farinella, V.F.; Kawafune, E.S.; Tangerina, M.M.P.; Domingos, H.V.; Costa-Lotufo, L.V.; Ferreira, M.J.P. OSMAC Strategy Integrated with Molecular Networking for Accessing Griseofulvin Derivatives from Endophytic Fungi of Moquiniastrum Polymorphum (Asteraceae). Molecules 2021, 26, 7316. [Google Scholar] [CrossRef]
- Armin, R.; Zühlke, S.; Grunewaldt-Stöcker, G.; Mahnkopp-Dirks, F.; Kusari, S. Production of Siderophores by an Apple Root-Associated Streptomyces Ciscaucasicus Strain GS2 Using Chemical and Biological OSMAC Approaches. Molecules 2021, 26, 3517. [Google Scholar] [CrossRef]
- Tanaka, M.; Shin-Ya, K.; Furihata, K.; Seto, H. Isolation and Structural Elucidation of Antioxidative Substances, Carbazoquinocins A to F. J. Antibiot. 1995, 48, 326–328. [Google Scholar] [CrossRef]
- Kashiwada, Y.; Nonaka, G.; Nishioka, I. Studies on Rhubarb (Rhei Rhizoma). V. Isolation and Characterization of Chromone and Chromanone Derivatives. Chem. Pharm. Bull. 1984, 32, 3493–3500. [Google Scholar] [CrossRef]
- Yeo, W.-H.; Yun, B.-S.; Kim, S.-S.; Park, E.-K.; Kim, Y.-H.; Yoo, I.-D.; Yu, S.-H. GTRI-02, a New Lipid Peroxidation Inhibitor from Micromonospora sp. SA246. J. Antibiot. 1998, 51, 952–953. [Google Scholar] [CrossRef] [PubMed]
- Kishi, T.; Muroi, M.; Kusaka, T.; Nishikawa, M.; Kamiya, K.; Mizuno, K. The Structure of Aristeromycin. Chemical & Pharmaceutical Bulletin 1972, 20, 940–946. [Google Scholar] [CrossRef]
- Patil, V.M.; Masand, N.; Verma, S.; Masand, V. Chromones: Privileged Scaffold in Anticancer Drug Discovery. Chemical Biology & Drug Design 2021, 98, 943–953. [Google Scholar] [CrossRef]
- Song, F.; Liu, D.; Huo, X.; Qiu, D. The Anticancer Activity of Carbazole Alkaloids. Archiv der Pharmazie 2022, 355, 2100277. [Google Scholar] [CrossRef]
- Uchiyama, N.; Tanaka, Y.; Kawamoto, T. Aristeromycin and DZNeP Cause Growth Inhibition of Prostate Cancer via Induction of Mir-26a. European Journal of Pharmacology 2017, 812, 138–146. [Google Scholar] [CrossRef]
- Crüsemann, M.; O’Neill, E.C.; Larson, C.B.; Melnik, A.V.; Floros, D.J.; da Silva, R.R.; Jensen, P.R.; Dorrestein, P.C.; Moore, B.S. Prioritizing Natural Product Diversity in a Collection of 146 Bacterial Strains Based on Growth and Extraction Protocols. J Nat Prod 2017, 80, 588–597. [Google Scholar] [CrossRef]
- Jensen, P.R.; Williams, P.G.; Oh, D.-C.; Zeigler, L.; Fenical, W. Species-Specific Secondary Metabolite Production in Marine Actinomycetes of the Genus Salinispora. Appl Environ Microbiol 2007, 73, 1146–1152. [Google Scholar] [CrossRef]
- Schlawis, C.; Harig, T.; Ehlers, S.; Guillen-Matus, D.G.; Creamer, K.E.; Jensen, P.R.; Schulz, S. Extending the Salinilactone Family. Chembiochem 2020, 21, 1629–1632. [Google Scholar] [CrossRef]
- Stratmann, A.; Schupp, T.; Toupet, C.; Schilling, W.; Oberer, L.; Traber, R. New Insights into Rifamycin B Biosynthesis: Isolation of Proansamycin B and 34a-Deoxy-Rifamycin W as Early Macrocyclic Intermediates Indicating Two Separated Biosynthetic Pathways. J Antibiot (Tokyo) 2002, 55, 396–406. [Google Scholar] [CrossRef]
- Jimenez, P.C.; Wilke, D.V.; Ferreira, E.G.; Takeara, R.; de Moraes, M.O.; da Silveira, E.R.; da Cruz Lotufo, T.M.; Lopes, N.P.; Costa-Lotufo, L.V. Structure Elucidation and Anticancer Activity of 7-Oxostaurosporine Derivatives from the Brazilian Endemic Tunicate Eudistoma Vannamei. Mar Drugs 2012, 10, 1092–1102. [Google Scholar] [CrossRef]
- Le Loarer, A.; Marcellin-Gros, R.; Dufossé, L.; Bignon, J.; Frédérich, M.; Ledoux, A.; Queiroz, E.F.; Wolfender, J.-L.; Gauvin-Bialecki, A.; Fouillaud, M. Prioritization of Microorganisms Isolated from the Indian Ocean Sponge Scopalina Hapalia Based on Metabolomic Diversity and Biological Activity for the Discovery of Natural Products. Microorganisms 2023, 11, 697. [Google Scholar] [CrossRef] [PubMed]
- Steele, A.D.; Teijaro, C.N.; Yang, D.; Shen, B. Leveraging a Large Microbial Strain Collection for Natural Product Discovery. J Biol Chem 2019, 294, 16567–16576. [Google Scholar] [CrossRef] [PubMed]
- Hindra; Huang, T. ; Yang, D.; Rudolf, J.D.; Xie, P.; Xie, G.; Teng, Q.; Lohman, J.R.; Zhu, X.; Huang, Y.; et al. Strain Prioritization for Natural Product Discovery by a High-Throughput Real-Time PCR Method. J Nat Prod 2014, 77, 2296–2303. [Google Scholar] [CrossRef] [PubMed]
- Jezkova, Z.; Binda, E.; Potocar, T.; Marinelli, F.; Halecky, M.; Branyik, T. Laboratory Scale Cultivation of Salinispora Tropica in Shake Flasks and Mechanically Stirred Bioreactors. Biotechnol Lett 2021, 43, 1715–1722. [Google Scholar] [CrossRef]
- Myers, O.D.; Sumner, S.J.; Li, S.; Barnes, S.; Du, X. One Step Forward for Reducing False Positive and False Negative Compound Identifications from Mass Spectrometry Metabolomics Data: New Algorithms for Constructing Extracted Ion Chromatograms and Detecting Chromatographic Peaks. Anal. Chem. 2017, 89, 8696–8703. [Google Scholar] [CrossRef]
- Rutz, A.; Sorokina, M.; Galgonek, J.; Mietchen, D.; Willighagen, E.; Gaudry, A.; Graham, J.G.; Stephan, R.; Page, R.; Vondrášek, J.; et al. The LOTUS Initiative for Open Knowledge Management in Natural Products Research. eLife 2022, 11, e70780. [Google Scholar] [CrossRef]
- Dührkop, K.; Nothias, L.-F.; Fleischauer, M.; Reher, R.; Ludwig, M.; Hoffmann, M.A.; Petras, D.; Gerwick, W.H.; Rousu, J.; Dorrestein, P.C.; et al. Systematic Classification of Unknown Metabolites Using High-Resolution Fragmentation Mass Spectra. Nat Biotechnol 2021, 39, 462–471. [Google Scholar] [CrossRef]
- Djoumbou Feunang, Y.; Eisner, R.; Knox, C.; Chepelev, L.; Hastings, J.; Owen, G.; Fahy, E.; Steinbeck, C.; Subramanian, S.; Bolton, E.; et al. ClassyFire: Automated Chemical Classification with a Comprehensive, Computable Taxonomy. Journal of Cheminformatics 2016, 8, 61. [Google Scholar] [CrossRef]
- Trager, W.; Jensen, J.B. Human Malaria Parasites in Continuous Culture. Science 1976, 193, 673–675. [Google Scholar] [CrossRef]



















| Compound ID | Molecular formula | Compound name or InChIKey (1,2,3) | Precursor ion area observed in MzMine (with the maximum in bold) according to the culture conditions |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medium | A1 | MB | ||||||||||||
| Support | Solid | Liquid | Solid | Liquid | ||||||||||
| Days | 7 | 14 | 21 | 7 | 14 | 21 | 14 | |||||||
| C82.1 | C44H80N2O15 | Megalomicin A (1,3) | 2,0E+02 | 3,0E+03 | 6,6E+03 | 1,0E+02 | 2,0E+02 | 2,0E+02 | 1,0E+02 | 5,0E+02 | ||||
| C82.2 | C45H78N2O17 | Megalomicin B (1,3) | 1,4E+02 | 5,2E+03 | 8,1E+03 | 2,0E+02 | 1,0E+03 | 1,0E+03 | - | 1,5E+03 | ||||
| C82.3 | C47H84N2O16 | 4’-Propionylmegalomicin A (1) | 1,0E+02 | 1,3E+03 | 2,2E+03 | 1,0E+02 | 3,0E+02 | 3,0E+02 | - | 6,0E+02 | ||||
| C82.4 | C48H84N2O17 | Megalomicin C1 (1,3) | 1,0E+02 | 3,5E+03 | 5,7E+03 | 3,3E+03 | 7,1E+03 | 6,7E+03 | - | 1,3E+03 | ||||
| C82.5 | C49H86N2O17 | Megalomicin C2 (1,3) | 1,0E+02 | 1,2E+03 | 1,7E+03 | 1,4E+03 | 3,4E+03 | 3,5E+03 | - | 1,1E+03 | ||||
| C82.6 | C39H69NO14 | 2’-O-Acetylerythromycin A (1) | 5,0E+02 | 8,0E+03 | 5,9E+03 | 6,0E+03 | 9,8E+03 | 1,2E+04 | 5,0E+01 | 4,2E+03 | ||||
| C82.7 | C36H65NO13 | Erythromycin C (1) | 6,7E+03 | 4,8E+04 | 4,9E+04 | 1,8E+04 | 3,0E+04 | 2,7E+04 | 1,0E+03 | 1,3E+04 | ||||
| C82.8 | C36H65NO13 | 13-Deethyl-13-methylerythromycin (1) | 4,8E+03 | 4,2E+03 | 2,0E+03 | 2,1E+04 | 4,5E+04 | 2,8E+04 | 5,0E+02 | 3,0E+03 | ||||
| C82.9 | C36H65NO12 | Erythromycin D (1) | 6,0E+03 | 1,3E+05 | 1,4E+05 | 6,8E+04 | 9,5E+04 | 7,0E+04 | 5,0E+02 | 1,7E+04 | ||||
| C82.10 | C37H67NO12 | Erythromycin B (1,3) | - | 1,5E+03 | 3,2E+03 | - | - | - | - | - | ||||
| C82.11 | C36H65NO12 | 6-Desmethyl erythromycin D (3) | 7,3E+02 | 4,3E+03 | 3,7E+03 | 1,0E+03 | 5,0E+02 | 5,0E+02 | 1,0E+02 | 1,0E+03 | ||||
| C82.12 | C29H53NO9 | 3-O-De(3-C,3-O-dimethyl-2,6-dideoxy-alpha-L-ribo-hexopyranosyl)-6-deoxyerythromycin (1) | - | 3,6E+03 | 5,5E+03 | - | - | - | 2,0E+02 | - | ||||
| C82.13 | C29H53NO9 | - | 8,0E+02 | 1,0E+03 | - | - | - | - | - | |||||
| C82.14 | C36H65NO12 | 6-Deoxy-3'-O-demethylerythromycin (1) | 1,0E+02 | 1,3E+03 | 1,6E+03 | 2,0E+03 | 1,0E+02 | 1,0E+02 | 1,0E+01 | 5,0E+01 | ||||
| C82.15 | C35H63NO13 | Norerythromycin (1) | 5,0E+02 | 1,0E+03 | 5,0E+02 | 5,0E+02 | 1,0E+03 | 1,4E+03 | 1,0E+02 | 1,9E+03 | ||||
| C82.16 | C21H38O7 | Erythronolide B (1) | 7,9E+04 | >2E+05* | >2E+05* | 8,0E+04 | 1,7E+05 | >2E+05* | 6,2E+04 | >2E+05* | ||||
| C82.17 | C20H36O7 | 2-Desmethyl-2-hydroxy-6-deoxyerythronolide B (1) | 1,0E+02 | 1,9E+03 | 1,1E+03 | 2,0E+02 | 7,0E+02 | 5,0E+02 | 5,0E+01 | 2,0E+02 | ||||
| C82.18 | C28H50O10 | 3-O-Alpha-mycarosylerythronolide B (1) | 1,5E+04 | 8,8E+04 | 1,3E+05 | 6,7E+04 | 1,5E+05 | 1,5E+05 | 8,8E+03 | 6,9E+04 | ||||
| C82.19 | C27H48O10 | 3-O-(alpha-L-olivosyl)erythronolide B (1) | 1,7E+03 | 1,2E+04 | 1,6E+04 | 4,2E+03 | 7,9E+03 | 7,3E+03 | 5,0E+02 | 4,3E+03 | ||||
| C82.20 | 5,0E+02 | 1,1E+03 | 2,0E+03 | 5,0E+02 | 1,7E+03 | 2,0E+03 | 5,0E+01 | 3,0E+02 | ||||||
| C82.21 | C21H38O6 | 6-Deoxyerythronolide B (1,3) | 2,5E+04 | 1,2E+05 | 1,4E+05 | 5,3E+04 | 6,9E+04 | 7,3E+04 | 1,5E+04 | 6,7E+04 | ||||
| Compound ID | Molecular formula | Compound name or InChIKey (1,2,3) | Precursor ion area observed in MzMine(with the maximum in bold) according to the culture conditions | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medium | A1 | MB | ||||||||||||
| Support | Solid | Liquid | Solid | Liquid | ||||||||||
| Days | 7 | 14 | 21 | 7 | 14 | 21 | 14 | |||||||
| C57.1 | C11H15N5O3 | 2-Deoxy-N6-methyladenosine (1) | 5,0E+02 | 9,8E+02 | 7,5E+02 | 1,7E+03 | 7,5E+02 | 3,8E+03 | 6,0E+01 | 3,0E+02 | ||||
| C57.2 | C11H15N5O | SXIDRQQQIPLCTJ (1) | 2,0E+02 | 2,0E+02 | 2,0E+02 | 2,0E+03 | 2,0E+03 | 6,8E+03 | - | - | ||||
| C57.3 | C11H13N5O3 | UHYRJPGYRFMFLT (1) | 9,9E+02 | 4,1E+02 | 1,5E+03 | 8,9E+03 | 9,1E+03 | 1,4E+04 | - | - | ||||
| C57.4 | C11H15N5 | 9-cyclopentyl-N-methylpurin-6-amine (1) | 5,5E+03 | 3,7E+03 | 4,1E+03 | 2,1E+04 | 2,0E+04 | 4,5E+04 | 2,8E+02 | 3,4E+03 | ||||
| C57.5 | C12H17N5OS | INPAYTORGXXLMB (1) | 3,7E+03 | 2,4E+03 | 6,4E+03 | 3,5E+04 | 2,7E+04 | 5,2E+04 | 1,0E+02 | 1,4E+03 | ||||
| C57.6 | C14H26N2O5S | JDNYVZBVEBRRCT (1) | 2,0E+02 | 3,0E+02 | 3,0E+02 | 5,0E+02 | 6,3E+02 | 2,4E+03 | - | 3,0E+02 | ||||
| C57.7 | C13H24NO5S | (?)-S-Acetylpantetheine (1) | 4,0E+02 | 1,0E+03 | 1,5E+03 | 6,2E+03 | 3,7E+03 | 7,0E+03 | - | 1,6E+03 | ||||
| C57.8 | C17H30N2O5S | ZCNIMMSEOJFZKZ (1) | - | - | - | 2,0E+02 | 1,3E+03 | 8,2E+03 | - | 1,0E+02 | ||||
| C57.9 | C19H28N2O5S | IXKOTSUCYPEFPP (1) | - | 1,0E+02 | 2,0E+02 | 8,0E+02 | 2,0E+03 | 5,1E+03 | - | 2,0E+02 | ||||
| C57.10 | C9H9NO | Indole-3-carbinol (1,2) | - | - | - | 6,0E+02 | 6,3E+02 | 1,3E+03 | - | - | ||||
| C57.11 | 1,0E+02 | 1,0E+02 | 1,0E+02 | 5,0E+02 | 7,2E+02 | 1,4E+03 | - | - | ||||||
| C57.12 | C13H12O4 | Aloesone (1) | - | 5,0E+01 | 1,0E+02 | 6,9E+03 | 3,1E+03 | 1,7E+03 | - | - | ||||
| C57.13 | C13H14O4 | Aloesol (1) | 5,0E+01 | 5,0E+01 | 5,0E+01 | 2,5E+03 | 6,2E+03 | 1,7E+04 | - | 2,0E+01 | ||||
| C57.14 | C20H23NO2 | Carbazoquinocin C (1,3) | - | - | 9,6E+02 | 8,0E+02 | 8,0E+02 | 6,2E+03 | - | - | ||||
| C57.15 | C21H25NO2 | Carbazoquinocin E (1,3) | - | - | - | - | - | 1,5E+03 | - | - | ||||
| C57.16 | C22H27NO2 | Carbazoquinocin F (1,3) | 5,0E+02 | 7,2E+02 | 4,5E+03 | 5,9E+02 | 6,1E+02 | 1,5E+04 | - | 6,0E+02 | ||||
| C57.17 | C24H31NO2 | 12-Carbazol-9-yldodecanoic acid (1) | - | - | - | - | 5,0E+02 | 7,7E+02 | - | - | ||||
| Compound ID | Molecular formula | Compound name or InChIKey (1,2,3) | Precursor ion area observed in MzMine (with the maximum in bold) according to the culture conditions |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Solvant | AcOEt | MeOH | |||||||||
| Support | Solid | Liquid | Solid | ||||||||
| Days | 7 d | 14 d | 21 d | 14 d | 14 d | ||||||
| C78.1 | C28H26N4O4 | OH staurosporine (1,2,3) | 2,4E+04 | 6,2E+04 | 1,8E+04 | 4,5E+03 | 1,3E+04 | ||||
| C78.2 | C28H26N4O3 | Staurosporine (1,2,3) | 2,4E+04 | 1,8E+04 | 7,6E+03 | 3,0E+03 | 3,2E+03 | ||||
| C78.3 | C29H28N4O4 | 4'-N-methyl-5'-hydroxy-staurosporine (1) | 1,3E+03 | 2,5E+03 | 9,6E+02 | 9,9E+02 | 4,3E+03 | ||||
| C78.4 | C28H24N4O5 | 4'-demethyl-Af-formyl-7V-hydroxy-staurosporine (1) | 4,0E+02 | 6,5E+02 | 4,5E+02 | - | - | ||||
| C78.5 | C37H45NO12 | Rifamycin S (1,2,3) | 3,0E+02 | 8,4E+03 | 2,5E+02 | 1,6E+04 | 2,5E+03 | ||||
| C78.6 | C36H43NO12 | 16-demethyl rifamycin S (3) | 4,5E+02 | 3,5E+03 | 3,0E+02 | 3,2E+03 | 9,9E+02 | ||||
| C78.7 | C35H45NO10 | 34a-deoxy-rifamycin W (1) | - | - | - | 2,0E+03 | - | ||||
| C78.8 | 4,0E+02 | 1,9E+03 | 3,0E+02 | 7,5E+02 | 1,0E+02 | ||||||
| C78.9 | C34H41NO10 | Proansamycin B (1,3) | 1,0E+03 | 1,0E+03 | 5,0E+02 | 3,0E+02 | - | ||||
| C78.10 | 3,0E+02 | 1,4E+03 | 1,0E+02 | 2,5E+03 | - | ||||||
| C78.11 | C34H41NO11 | Demethyl-desacetyl-rifamycin S (1) | 2,0E+02 | 1,2E+03 | 2,0E+02 | 1,2E+04 | 5,0E+02 | ||||
| C78.12 | C37H45NO13 | 20-hydroxyrifamycin S (1,3) | - | - | - | 1,9E+03 | - | ||||
| C78.13 | C35H42NO12 | 30-hydroxyrifamycin W (1) | 5,0E+01 | 5,6E+02 | - | 7,4E+02 | - | ||||
| C78.14 | C22H37NO5 | Saliniketal A (1,3) | 1,8E+04 | 3,1E+04 | 2,2E+04 | 3,3E+04 | 4,6E+03 | ||||
| C78.15 | C22H37NO6 | Saliniketal B (1,3) | 5,4E+03 | 7,7E+03 | 6,9E+03 | 6,6E+03 | 7,0E+02 | ||||
| C78.16 | C8H10O3 | Salinilactone D (3) | 8,0E+02 | 3,5E+02 | 6,0E+02 | 4,0E+04 | - | ||||
| C78.17 | C9H12O3 | Salinilactone E (3) | - | 6,0E+02 | - | 3,4E+04 | - | ||||
| C78.18 | 9,0E+03 | 7,6E+03 | 7,3E+03 | 1,1E+05 | 2,0E+02 | ||||||
| C78.19 | C10H14O3 | Salinilactone A (3) | 3,0E+02 | 3,0E+02 | 3,0E+02 | 7,0E+03 | - | ||||
| C78.20 | 4,0E+02 | 4,0E+02 | 4,0E+02 | 8,6E+03 | - | ||||||
| C78.21 | 4,0E+02 | 4,0E+02 | 4,0E+02 | 1,0E+04 | - | ||||||
| C78.22 | C11H16O3 | Salinilactone C (3) | 3,0E+03 | 3,7E+03 | 2,5E+03 | 1,4E+04 | - | ||||
| C78.23 | C12H18O3 | Salinilactone H (3) | 1,0E+03 | 2,0E+03 | 8,0E+02 | 1,5E+04 | - | ||||
| Class | Species | Code strain | Selected Regions for Genetic Characterization |
|---|---|---|---|
| Actinobacteria | Micromonospora sp. | SH-82 | ADNr 16s (from V1 to V5) |
| Micromonospora sp. | SH-57 | ||
| Salinispora arenicola | SH-78 |
| Microbial strains | Days | Support | Culture Medium |
|---|---|---|---|
| Micromonospora sp. SH-82 Micromonospora sp. SH-57 | 7/14/21 | Solid/Liquid | A1BFe+C |
| 14 | MB | ||
| Salinispora arenicola SH-78 | 7/14/21 | Solid | A1BFe+C |
| 14 | Liquid |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).